Skip to main content
PMC home page
The BMJ logoLink to The BMJ
. 1996 May 18;312(7041):1279–1283. doi: 10.1136/bmj.312.7041.1279

Diagnosis and management of migraine.

P J Goadsby 1, J Olesen 1
PMCID: PMC2351074  PMID: 8634619

Full text

PDF
1279

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Goadsby P. J., Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol. 1993 Jan;33(1):48–56. doi: 10.1002/ana.410330109. [DOI] [PubMed] [Google Scholar]
  2. Goadsby P. J., Zagami A. S., Donnan G. A., Symington G., Anthony M., Bladin P. F., Lance J. W. Oral sumatriptan in acute migraine. Lancet. 1991 Sep 28;338(8770):782–783. doi: 10.1016/0140-6736(91)90666-d. [DOI] [PubMed] [Google Scholar]
  3. Goadsby P. J., Zagami A. S., Lambert G. A. Neural processing of craniovascular pain: a synthesis of the central structures involved in migraine. Headache. 1991 Jun;31(6):365–371. doi: 10.1111/j.1526-4610.1991.hed3106365.x. [DOI] [PubMed] [Google Scholar]
  4. Hering R., Kuritzky A. Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Cephalalgia. 1992 Apr;12(2):81–84. doi: 10.1046/j.1468-2982.1992.1202081.x. [DOI] [PubMed] [Google Scholar]
  5. Humphrey P. P., Goadsby P. J. The mode of action of sumatriptan is vascular? A debate. Cephalalgia. 1994 Dec;14(6):401–393. doi: 10.1046/j.1468-2982.1994.1406401.x. [DOI] [PubMed] [Google Scholar]
  6. Jensen R., Brinck T., Olesen J. Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study. Neurology. 1994 Apr;44(4):647–651. doi: 10.1212/wnl.44.4.647. [DOI] [PubMed] [Google Scholar]
  7. Langemark M., Olesen J. Drug abuse in migraine patients. Pain. 1984 May;19(1):81–86. doi: 10.1016/0304-3959(84)90067-8. [DOI] [PubMed] [Google Scholar]
  8. Moskowitz M. A., Cutrer F. M. SUMATRIPTAN: a receptor-targeted treatment for migraine. Annu Rev Med. 1993;44:145–154. doi: 10.1146/annurev.me.44.020193.001045. [DOI] [PubMed] [Google Scholar]
  9. Olesen J. Analgesic headache. BMJ. 1995 Feb 25;310(6978):479–480. doi: 10.1136/bmj.310.6978.479. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Olesen J. Cerebral and extracranial circulatory disturbances in migraine: pathophysiological implications. Cerebrovasc Brain Metab Rev. 1991 Spring;3(1):1–28. [PubMed] [Google Scholar]
  11. Rasmussen B. K. Epidemiology of headache. Cephalalgia. 1995 Feb;15(1):45–68. doi: 10.1046/j.1468-2982.1995.1501045.x. [DOI] [PubMed] [Google Scholar]
  12. Russell M. B., Iversen H. K., Olesen J. Improved description of the migraine aura by a diagnostic aura diary. Cephalalgia. 1994 Apr;14(2):107–117. doi: 10.1046/j.1468-2982.1994.1402107.x. [DOI] [PubMed] [Google Scholar]
  13. Russell M. B., Rasmussen B. K., Brennum J., Iversen H. K., Jensen R. A., Olesen J. Presentation of a new instrument: the diagnostic headache diary. Cephalalgia. 1992 Dec;12(6):369–374. doi: 10.1111/j.1468-2982.1992.00369.x. [DOI] [PubMed] [Google Scholar]
  14. Scharff L., Turk D. C., Marcus D. A. Triggers of headache episodes and coping responses of headache diagnostic groups. Headache. 1995 Jul-Aug;35(7):397–403. doi: 10.1111/j.1526-4610.1995.hed3507397.x. [DOI] [PubMed] [Google Scholar]
  15. Tfelt-Hansen P., Henry P., Mulder L. J., Scheldewaert R. G., Schoenen J., Chazot G. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet. 1995 Oct 7;346(8980):923–926. doi: 10.1016/s0140-6736(95)91554-0. [DOI] [PubMed] [Google Scholar]
  16. Treatment of migraine attacks with sumatriptan. The Subcutaneous Sumatriptan International Study Group. N Engl J Med. 1991 Aug 1;325(5):316–321. doi: 10.1056/NEJM199108013250504. [DOI] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES